Related references
Note: Only part of the references are listed.Introduction to current and future protein therapeutics: A protein engineering perspective
Paul J. Carter
EXPERIMENTAL CELL RESEARCH (2011)
Antibody-Mediated Coengagement of FcγRIIb and B Cell Receptor Complex Suppresses Humoral Immunity in Systemic Lupus Erythematosus
Holly M. Horton et al.
JOURNAL OF IMMUNOLOGY (2011)
Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia
R. Handgretinger et al.
LEUKEMIA (2011)
Ligand association rates to the inner-variable-domain of a dual-variable-domain immunoglobulin are significantly impacted by linker design
Enrico L. DiGiammarino et al.
MABS (2011)
Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects APPLICATIONS TO BISPECIFIC MOLECULES AND MONOVALENT IgG
Kannan Gunasekaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Enhanced antibody half-life improves in vivo activity
Jonathan Zalevsky et al.
NATURE BIOTECHNOLOGY (2010)
SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies
Jonathan H. Davis et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Protein design automation
Bassil I. Dahiyat et al.
PROTEIN SCIENCE (2010)
Bispecific T-Cell Engaging Antibodies for Cancer Therapy
Patrick A. Baeuerle et al.
CANCER RESEARCH (2009)
Lethal Effect of CD3-Specific Antibody in Mice Deficient in TGF-β1 by Uncontrolled Flu-Like Syndrome
Sylvain Perruche et al.
JOURNAL OF IMMUNOLOGY (2009)
An Unfolded CH1 Domain Controls the Assembly and Secretion of IgG Antibodies
Matthias J. Feige et al.
MOLECULAR CELL (2009)
Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR
Jennifer S. Michaelson et al.
MABS (2009)
Bispecific antibodies for cancer therapy The light at the end of the tunnel?
Patrick Chames et al.
MABS (2009)
Molecular construction and optimization of anti-human IL-1α/β dual variable domain immunoglobulin (DVD-Ig™) molecules
Chengbin Wu et al.
MABS (2009)
Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
Jenny Bostrom et al.
SCIENCE (2009)
Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells
John O. Richards et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies
Seung Y. Chu et al.
MOLECULAR IMMUNOLOGY (2008)
Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin
Chengbin Wu et al.
NATURE BIOTECHNOLOGY (2007)
CD3-specific antibodies: a portal to the treatment of autoimmunity
Lucienne Chatenoud et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Single variable domain-IgG fusion - A novel recombinant approach to Fc domain-containing bispecific antibodies
JQ Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Engineered antibody Fc variants with enhanced effector function
GA Lazar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Deconstructing the form and function of the TCR/CD3 complex
MS Kuhns et al.
IMMUNITY (2006)
CD16 polymorphisms and NK activation induced by monoclonal antibody-coated target cells
JA Bowles et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity
D Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Engineered antibody fragments and the rise of single domains
P Holliger et al.
NATURE BIOTECHNOLOGY (2005)
A recombinant bispecific single-chain Fv antibody against HLA class II and FcγRIII (CD16) triggers effective lysis of lymphoma cells
J Bruenke et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
A method for simultaneous alignment of multiple protein structures
M Shatsky et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
Effect of tetravalent bispecific CD19 x CD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells
U Reusch et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Crystal structure of the human T cell receptor CD3εγ heterodimer complexed to the therapeutic mAb OKT3
L Kjer-Nielsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells
Y Durocher et al.
NUCLEIC ACIDS RESEARCH (2002)
The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex
P Sondermann et al.
NATURE (2000)
An efficient route to the production of an IgG-like bispecific antibody
Z Zuo et al.
PROTEIN ENGINEERING (2000)
Share Paper
